Exemestane
NDC 51991-005, Exemestane, tablet, film coated, from Breckenridge Pharmaceutical, Inc..
- Product NDC
- 51991-005
- Status
- Listed
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211031
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51991-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EXEMESTANE25 mg/1
Pharmacologic classes
Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51991-005-90 | 51991000590 | 90 TABLET, FILM COATED in 1 BOTTLE (51991-005-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4e3fd382-19f5-4ded-ab22-39d5b1b2f366NADAC price for package 51991000590
GET /v1/drugs/nadac/51991000590
Use it
Look up 51991-005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51991-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51991-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.